AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19031218
Drug: Trifolium pratense-derived
RxNorm normalized name: Trifolium pratense pollen
DrugBank: Trifolium pratense pollen (DB15530)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trifolium pratense-derived isoflavones (80 mg red clover isoflavones) daily for 90 days
Trial: 17558069
Drug: Enteral glutamine
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enteral glutamine 45 g/day for 5 days in addition to standard care (group A)
Trial: 1505614
Drug: Indomethacin 25
RxNorm normalized name: indomethacin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 25 mg tid for 6 days (elderly subjects)
Trial: 28089225
Drug: Group treatment
RxNorm normalized name: Allergenic Extracts Intradermal Kit [9 SO. GRASS GROUP TREATMENT SET]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group treatment
Trial: 22481427
Drug: MF59-adjuvanted formulations
RxNorm normalized name: Hep B, unspecified formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted formulations
Trial: 10090490
Drug: Concentrated oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concentrated oxytocin plus low-dose vaginal prostaglandin E2 (10 mg q 6 h)
Trial: 7788255
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride (TCl) 20 mg twice daily
Trial: 7788255
Drug: Oxybutynin (Oxy)
DrugBank: Oxybutynin (DB01062)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxybutynin (Oxy) 5 mg three times daily
Trial: 6794592
Drug: Oral disodium
RxNorm normalized name: etidronate disodium Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral disodium cromoglycate (DSCG)
Trial: 19366272
Drug: Solifenacin 5
RxNorm normalized name: solifenacin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin 5 mg/day
Trial: 25711955
Drug: Higher-protein (HP)
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher-protein (HP) breakfast (32 g protein)
Trial: 1103897
Drug: oral application
RxNorm normalized name: Oral Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral application of AR-DF 26
Trial: 20642488
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg i.v.-ibuprofen every 6 hours
Trial: 7350203
Drug: Intranasal flunisolide
RxNorm normalized name: Flunisolide
DrugBank: Flunisolide acetate (DB14662)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal flunisolide 200 micrograms/day
Trial: 18179756
Drug: Intranasal flunisolide
RxNorm normalized name: Flunisolide
DrugBank: Flunisolide acetate (DB14662)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal flunisolide
Trial: 26852726
Drug: Oral solithromycin
RxNorm normalized name: roxithromycin Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral solithromycin (800 mg on day 1, 400 mg on days 2-5, placebo on days 6-7)
Trial: 31749051
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide (FAc) implant
Trial: 11052557
Drug: Pill organizer
RxNorm normalized name: Ezy Dose Weekly AM/PM Pill Organizer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pill organizer
Trial: 17944770
Drug: Ibandronate 6
RxNorm normalized name: ibandronate
DrugBank: Ibandronate (DB00710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibandronate 6 mg intravenous infusion
Trial: 24814857
Drug: DFPP combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DFPP combined with oral methylprednisolone
Trial: 26012297
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with azelastine and fluticasone propionate
Trial: 3290356
Drug: Ketanserin treatment
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin treatment
Trial: 7304485
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum (9.0 g/day)
Trial: 23021480
Drug: Community treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community treatment as usual
Trial: 8163050
Drug: Amylin infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amylin infusion for 6 hours during postabsorptive and euglycaemic hyperinsulinaemic clamp phases.
Trial: 27487463
Drug: Ofloxacin eye
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin eye drops administered the day before IVI (four times)
Trial: 17314337
Drug: Combination regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination regimen of salmeterol plus fluticasone
Trial: 19469296
Drug: Morphine 0.5
RxNorm normalized name: morphine 0.5 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 0.5 mg/ml + ketamine 0.5 mg/ml (MK-group)
Trial: 18489634
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg oxycodone/325 mg acetaminophen
Trial: 25877710
Drug: Bromfenac sodium
RxNorm normalized name: Bromfenac Sodium
DrugBank: Bromfenac (DB00963)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bromfenac sodium ophthalmic solution 0.1%
Trial: 14693783
Drug: Deep sclerectomy
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep sclerectomy with collagen implant (DSCI)
Trial: 2252531
Drug: Combined azathioprine
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Combined azathioprine and thymostimulin administration
Trial: 27489178
Drug: Migraine-specific medication
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Migraine-specific medication (MSM)
Trial: 15040827
Drug: Raloxifene 60
RxNorm normalized name: raloxifene 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene 60 or 120 mg/day for 3 years
Trial: 31278067
Drug: Epigallocatechin gallate
RxNorm normalized name: Epigallocatechin Gallate
DrugBank: Epigallocatechin gallate (DB12116)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epigallocatechin gallate (400 mg capsule, orally once daily for 4 weeks, then twice daily for 4 weeks, then three times daily for 40 weeks)
Trial: 20693299
Drug: Paclitaxel (Taxol)
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel (Taxol) (50 mg/mq) combined with non-pegylated liposomal anthracycline (25 mg/mq)
Trial: 20693299
Drug: Docetaxel (Taxotere)
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel (Taxotere) (30 mg/mq) combined with non-pegylated liposomal anthracycline (25 mg/mq)
Trial: 20453635
Drug: Low-dose gemcitabine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose gemcitabine and cisplatin
Trial: 29683370
Drug: Bao Khi
RxNorm normalized name: SODIUM HYPOCHLORITE 1 mg in 1 L EXTRACORPOREAL LIQUID [QIAN BAO Disinfectant]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bao Khi Khang tablets combined with standard therapeutic protocol (Antimicrobial+Corticosteroids+Bronchodilator+Mucolytic drugs)
Trial: 22842201
Drug: Staining solution
RxNorm normalized name: fluorexon stain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Staining solution (coffee) with AccessCrown material
Trial: 22842201
Drug: Staining solution
RxNorm normalized name: fluorexon stain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Staining solution (coffee) with Structur2 SC material
Trial: 16353041
Drug: Ticlopidine (TIC)
DrugBank: Ticlopidine (DB00208)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticlopidine (TIC) 500 mg BID for 2 days and 250 mg BID for subsequent 5 days
Trial: 18284648
Drug: Renzapride 4
RxNorm normalized name: Renzapride
DrugBank: Renzapride (DB04917)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Renzapride 4 mg/day
Trial: 29549598
Drug: Adapalene 0.3%
RxNorm normalized name: ADAPALENE 0.3% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adapalene 0.3% gel
Trial: 15661475
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation, 60 mg retinol equivalent every 3 months
Trial: 795437
Drug: Trasylol (aprotinin)
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trasylol (aprotinin) treatment
Trial: 27524671
Drug: Training group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Training group with monthly bisphosphonate regimen
Trial: 11520368
Drug: Monthly regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly regimen
Trial: 24888479
Drug: WELLFOCUS PPT
RxNorm normalized name: PPT
DrugBank: Podofilox (DB01179)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WELLFOCUS PPT (11-session group therapy in addition to treatment as usual)
Trial: 11432326
Drug: Flonivin BS
RxNorm normalized name: BS-001
DrugBank: BS-001 (DB17415)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flonivin BS (Bacillus Subtilis IP 5832), 3 x 2 capsules daily for 7 days
Trial: 30389671
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor (ACEI)/angiotensin receptor blocker (ARB) prescriptions
Trial: 26365745
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids (ICS) withdrawal
Trial: 10522184
Drug: Implant-retained overdenture
RxNorm normalized name: betaine
DrugBank: Betaine (DB06756)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Implant-retained overdenture (IRO-group)
Trial: 19496943
Drug: Intraduodenal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraduodenal administration of increasing Ac doses (12.5/25/50/100 mg Ac in 50 mL water).
Trial: 10378552
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) 60 mg daily for 14 days
Trial: 26265643
Drug: AREDS formulation
RxNorm normalized name: AR-9281
DrugBank: AR-9281 (DB06345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AREDS formulation followed by ranibizumab
Trial: 15108768
Drug: Sirolimus (SRL)
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus (SRL) 2 mg/d
Trial: 12064813
Drug: Rufloxacin 400
RxNorm normalized name: ofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rufloxacin 400 mg/week
Trial: 11555505
Drug: Target-flow inspiratory
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Target-flow inspiratory muscle training (IMT) at 60 to 70% SIPmax, 30 min daily, 6 days a week for 6 months
Trial: 30730438
Drug: Goal-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed therapy
Trial: 25425475
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid 4 mg intravenously every 4 weeks (Q4W)
Trial: 24535482
Drug: 13.5 mg
RxNorm normalized name: niacin 13.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 13.5 mg hyperbaric bupivacaine with 2 mg preservative-free ketorolac
Trial: 15598480
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg OD
Trial: 2225410
Drug: Aspirin 325
RxNorm normalized name: aspirin 325 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 325 mg q.d.
Trial: 12284145
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 10 mg pessaries
Trial: 27630374
Drug: 880µg of
RxNorm normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 880µg of intravitreal sirolimus administered on days 0, 60, and 120
Trial: 12859302
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg i.v.
Trial: 18423628
Drug: Intravenous lansoprazole
RxNorm normalized name: Lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lansoprazole (90‐mg bolus followed by 9‐mg/h infusion)
Trial: 16324861
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of morphine 0.1 mg kg(‐1) with ketamine 0.15 mg kg(‐1) (group KM)
Trial: 18423628
Drug: Intravenous lansoprazole
RxNorm normalized name: Lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lansoprazole
Trial: 21810288
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose oat β‐glucan (3·0 g β‐glucan; oats high ‐ OH) in responders
Trial: 23816448
Drug: Group psychoeducation
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group psychoeducation (21 sessions, weekly)
Trial: 15482167
Drug: Thymalfasin (Talpha1)
RxNorm normalized name: thymalfasin
DrugBank: Thymalfasin (DB04900)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymalfasin (Talpha1) 1.6 mg twice-weekly for 6 months
Trial: 15482167
Drug: Thymalfasin (Talpha1)
RxNorm normalized name: thymalfasin
DrugBank: Thymalfasin (DB04900)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymalfasin (Talpha1) and interferon combination therapy
Trial: 29049935
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (IN-OT)
Trial: 23698496
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg + bupivacaine 0.5%
Trial: 23698496
Drug: Saline 2
RxNorm normalized name: SODIUM CHLORIDE BRONCHO-SALINE 240ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline 2 mL + bupivacaine 0.5%
Trial: 10863994
Drug: Low-salt diet
RxNorm normalized name: Low-energy diets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-salt diet (LS; sodium chloride intake <5 g per day)
Trial: 1625504
Drug: Omeprazole-treated patients
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole-treated patients re-examined 10 days after drug withdrawal
Trial: 3960476
Drug: Topical Indomethacin
RxNorm normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical Indomethacin and topical steroid treatment
Trial: 3365283
Drug: Alcohol (1
RxNorm normalized name: POLYVINYL ALCOHOL (18000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (1 g/kg)
Trial: 30176632
Drug: Cimicifuga racemosa
RxNorm normalized name: CIMICIFUGA RACEMOSA ROOT
DrugBank: Black cohosh (DB13975)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimicifuga racemosa extract BNO 1055 added to standard treatment
Trial: 12057714
Drug: Raloxifene, 60
RxNorm normalized name: Raloxifene, 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene, 60 mg/d for 3 months
Trial: 27829454
Drug: 4-week dose
RxNorm normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-week dose reduction group (N = 125)
Trial: 24088010
Drug: Horse riding
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Horse riding therapy (six 30-minute sessions)
Trial: 10994157
Drug: Oral enzyme
RxNorm normalized name: alpha-D-galactosidase enzyme Disintegrating Oral Tablet [Beano]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral enzyme combination product (OE; Phlogenzym(®), containing trypsin, bromelain and rutin)
Trial: 10994157
Drug: Oral enzyme
RxNorm normalized name: alpha-D-galactosidase enzyme Disintegrating Oral Tablet [Beano]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral enzyme combination product (OE)
Trial: 9312762
Drug: Non-steroidal anti-inflammatory
RxNorm normalized name: Non-steroidal anti-inflammatory agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroidal anti-inflammatory drugs (NSAID)
Trial: 8791954
Drug: Amoxycillin 750
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 750 mg b.d. + placebo
Trial: 17898099
Drug: Statins treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statins treatment with varying HDL cholesterol levels
Trial: 355604
Drug: Best conventional
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best conventional care (no chemotherapy or radiotherapy)
Trial: 18030066
Drug: Prasugrel 10-mg
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 10-mg MD
Trial: 8604671
Drug: Oral riboflavin
RxNorm normalized name: riboflavin Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral riboflavin (60 mg)
Trial: 8843991
Drug: Intravenous riboflavin
RxNorm normalized name: Riboflavin
DrugBank: Riboflavin (DB00140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous riboflavin (11.6 mg)
Trial: 31221882
Drug: Potent topical
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potent topical corticosteroid (TCS) once daily
Trial: 19561542
Drug: Infliximab therapy
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab therapy (3-dose induction regimen)
Trial: 11157525
Drug: Nasal diamorphine
RxNorm normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal diamorphine spray
Trial: 8451894
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g Cefuroxim (n = 70)
Trial: 23948125
Drug: Linagliptin 5
RxNorm normalized name: linagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linagliptin 5 mg once daily for 24 weeks
Trial: 27733388
Drug: 10 mM
RxNorm normalized name: potassium 10 MMOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mM ketorolac (nonselective COX inhibitor)
Trial: 27733388
Drug: 10 mM
RxNorm normalized name: potassium 10 MMOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mM NG‐nitro‐l‐arginine methyl ester (nonselective NOS inhibitor)
Trial: 11313839
Drug: sertraline
RxNorm normalized name: Sertraline
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sertraline
Trial: 29273872
Drug: Intravenous lansoprazole
RxNorm normalized name: Lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lansoprazole (30 mg) as a continuous infusion twice daily for 3 days starting the day before ESD, followed by lansoprazole OD tablets (30 mg) orally once daily on days 4-56
Trial: 23616513
Drug: Wheat rolls
RxNorm normalized name: WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat rolls fortified with microencapsulated L-5-methyltetrahydrofolic acid (452 μg/d)
Trial: 19728370
Drug: Lenalidomide 5
RxNorm normalized name: lenalidomide 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenalidomide 5 mg
Trial: 18855269
Drug: 40 mg/day
RxNorm normalized name: cabozantinib s-malate 140 mg/day (80 mg x 1-20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/day telmisartan
Trial: 18559649
Drug: Artemisone 80
RxNorm normalized name: Artemisone
DrugBank: Artemisone (DB16097)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artemisone 80 mg (single dose)
Trial: 19403270
Drug: Social recovery
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social recovery orientated cognitive behavioural therapy (SRCBT)
Trial: 9374251
Drug: Latanoprost 50
RxNorm normalized name: Latanoprost 50 microgram/mL eye drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latanoprost 50 microg/ml, three drops once daily
Trial: 3050087
Drug: Folinic acid
RxNorm normalized name: Folinic acid
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Folinic acid 20 mg/week
Trial: 8977677
Drug: Tacalcitol ointment
RxNorm normalized name: tacalcitol
DrugBank: Tacalcitol (DB13689)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacalcitol ointment (4 micrograms/g, once daily for 8 weeks)
Trial: 24722960
Drug: 6-month telephone-based
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month telephone-based health coaching intervention (11 sessions using acceptance and commitment therapy strategies)
Trial: 6421424
Drug: Beef ultralente
RxNorm normalized name: INSULIN BEEF ULTRALENTE 100U/ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beef ultralente insulin